Evidence map›Paper›PMID 40686464›Full record

ArticleMovement disorders : official journal of the Movement Disorder Society2025

Reliability of Neuroimaging and Neurophysiological Tremor Features in Parkinson's Disease.

Luca Angelini, Kevin van den Berg, Michiel Dirkx, Matteo Bologna, Bastiaan R Bloem, Rick C G Helmich

Abstract read
In one paragraph

Article in Movement disorders : official journal of the Movement Disorder Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Temporal Dynamics of Parkinson's Disease Tremor: Clinical and Neuroimaging Insights.Movement disorders : official journal of the Movement Disorder Society · 2026
    Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Luca AngeliniIRCCS Neuromed, Pozzilli, Italy.ORCID https://orcid.org/0000-0002-6601-7476
Kevin van den BergCentre for Cognitive Neuroimaging, Donders Institute for Brain, Cognition and Behaviour, Radboud University Nijmegen, Nijmegen, The Netherlands.ORCID https://orcid.org/0000-0002-8971-4282
Michiel DirkxCentre for Cognitive Neuroimaging, Donders Institute for Brain, Cognition and Behaviour, Radboud University Nijmegen, Nijmegen, The Netherlands.ORCID https://orcid.org/0000-0001-8763-8071
Matteo BolognaIRCCS Neuromed, Pozzilli, Italy.ORCID https://orcid.org/0000-0003-0165-0833
Bastiaan R BloemDepartment of Neurology, Center of Expertise for Parkinson and Movement Disorders, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Centre, Nijmegen, The Netherlands.ORCID https://orcid.org/0000-0002-6371-3337
Rick C G HelmichCentre for Cognitive Neuroimaging, Donders Institute for Brain, Cognition and Behaviour, Radboud University Nijmegen, Nijmegen, The Netherlands.ORCID https://orcid.org/0000-0003-4035-6573

Funding

International Federation of Clinical NeurophysiologyZonMw - The Netherlands Organization for Health Research and Development 91215208
6 · The paper itself

Abstract

backgroundTremor is one of the cardinal motor symptoms of Parkinson's disease (PD). Its severity can be quantified with clinical rating scales and neurophysiology. The pathophysiology of PD tremor involves activity in the cerebello-thalamo-cortical circuit (CTC), which can be quantified with concurrent accelerometry-functional magnetic resonance imaging (fMRI). This opens possibilities for fMRI-informed precision medicine, but it remains unclear if tremor-related fMRI activity is a reliable biomarker at the individual level.

objectivesTo assess the test-retest reliability of three PD tremor outcome measures: clinical rating scales, accelerometry, and combined accelerometry-fMRI.

methodsWe studied 26 tremor-dominant PD patients OFF medication on two separate days (2-month interval). On each day, tremor was characterized with clinical rating scales (Fahn-Tolosa-Marin Tremor Rating Scale), accelerometry, and concurrent accelerometry-fMRI. Reliability was assessed using Spearman correlations and intraclass correlation coefficients.

resultsClinical and neurophysiological tremor parameters were reliable across sessions. Resting tremor-related fMRI activity was observed within the CTC across both sessions. The amplitude of tremor-related activity in motor cortex and cerebellum had a significant, but moderate, between-session reliability. Furthermore, the activity-by-voxel distribution of tremor-related activity within motor cortex and cerebellum showed a significant between-session correlation in at least two-thirds of patients, and intra-individual variability was significantly lower than inter-individual variability.

conclusionsBoth the amplitude and location of resting tremor-related activity in motor cortex and cerebellum, derived from concurrent accelerometry-fMRI, are replicable between sessions. This suggests that accelerometry-fMRI may be used as an individual biomarker for tremor pathophysiology, to guide intervention studies and assess target engagement of new anti-tremor therapies. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Indexed as

CerebellumNeuroimagingParkinson DiseaseTremorAccelerometryAgedFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedReproducibility of ResultsSeverity of Illness Indexfunctional neuroimagingneurophysiologyParkinson's diseasetremor

Identifiers

PMID40686464
PMCPMC12553995

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.